Summary
A study published in Nature on July 15, 2026, identified cell-type-specific molecular signatures associated with cognitive impairment and Alzheimer's disease across diverse population groups. This research utilized single-nucleus RNA-seq and ATAC-seq analyses on post-mortem brain samples from African American, Latin, and white individuals.